
Doctor Anna Borowiec
National Institute of Oncology, Warsaw, Poland, Warsaw (Poland)
Membership:
ESC Professional Member
EACVI Member
HFA Member
Follow
Contributor content
Session
Time to use SGLT2-inhibitors in cardio-oncology?
20 June 2026
Session
Preventing cardiotoxicity
19 June 2026


